|
[Related PubMed/MEDLINE]
Total Number of Papers: 546
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: RXRs |
| Long Form |
: retinoid X receptors |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Modulation of Rxrα Expression in Mononuclear Phagocytes Impacts on Cardiac Remodeling after Ischemia-Reperfusion Injury. |
MI |
| 2 |
2022 |
Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement. |
--- |
| 3 |
2022 |
Retinoid-X receptor agonists increase thyroid hormone competence in lower jaw remodeling of pre-metamorphic Xenopus laevis tadpoles. |
NRs, TH, TRs |
| 4 |
2022 |
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro. |
ATRA, RARs |
| 5 |
2022 |
The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer. |
--- |
| 6 |
2022 |
The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells. |
RARs, SMI |
| 7 |
2021 |
GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling. |
DN, ECM, MCs, PAI-1, PPARgamma, RARs |
| 8 |
2021 |
Molting process revealed by the detailed expression profiles of RXR1/RXR2 and mining the associated genes in a spider mite, Panonychus citri. |
EcR |
| 9 |
2021 |
Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. |
APL, ATRA, RARs |
| 10 |
2021 |
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10. |
HCC, MICA, NK, RARs, sMICA |
| 11 |
2021 |
Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. |
AD, MCI, RA, RARbeta, ROS, RXRgamma, VitA |
| 12 |
2021 |
Structural Insights into the Interaction of the Intrinsically Disordered Co-activator TIF2 with Retinoic Acid Receptor Heterodimer (RXR/RAR). |
LBD, NR, RARs |
| 13 |
2021 |
The Interactions of Insulin and Vitamin A Signaling Systems for the Regulation of Hepatic Glucose and Lipid Metabolism. |
RA, RARs, VA |
| 14 |
2021 |
The multi-faceted role of retinoid X receptor in cardiovascular diseases. |
FAs, NRs |
| 15 |
2021 |
The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology. |
RARs |
| 16 |
2021 |
The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer. |
--- |
| 17 |
2021 |
Thyroid hormone and thyroid hormone nuclear receptors: History and present state of art. |
TRs |
| 18 |
2021 |
Vitamin A5/X controls stress-adaptation and prevents depressive-like behaviors in a mouse model of chronic stress. |
9CDHRA |
| 19 |
2020 |
Computational determination of human PPARG gene: SNPs and prediction of their effect on protein functions of diabetic patients. |
PPARG |
| 20 |
2020 |
Design of synthetic retinoids. |
RARs |
| 21 |
2020 |
Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers. |
LBD, LBP, RXR |
| 22 |
2020 |
DNA recognition by retinoic acid nuclear receptors. |
DBDs, ESI-MS, ITC, RARs |
| 23 |
2020 |
Fluorescence properties of retinoid X receptor antagonist NEt-SB. |
--- |
| 24 |
2020 |
In utero exposure to phenanthrene induces hepatic steatosis in F1 adult female mice. |
PAHs, PHE |
| 25 |
2020 |
Long-term exposure to phenanthrene at environmental-level induces intestinal dysbiosis and disrupted hepatic lipid metabolism in mice. |
FMT, LXRbeta, PAHs, PHE, PPARs |
| 26 |
2020 |
Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action. |
CAR, FXR, LXRs, PPARs, PXR, TRs |
| 27 |
2020 |
Natural ligands of RXR receptors. |
HTS, NR |
| 28 |
2020 |
Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development. |
AR, ER, GR, LXRs, NRs, PPARs, RARs, TR |
| 29 |
2020 |
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses. |
GVHD, NR |
| 30 |
2020 |
Structural basis for DNA recognition and allosteric control of the retinoic acid receptors RAR-RXR. |
RAREs, RARs |
| 31 |
2020 |
VHL enhances 9-cis-retinoic acid treatment by down-regulating retinoid X receptor alpha in renal cell carcinomas. |
RCC, VHL |
| 32 |
2019 |
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. |
--- |
| 33 |
2019 |
A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation. |
BAL, CSE, CXCL5, IFN, KC, MMP-9, NR, PPE, TIMP-1, VEGF |
| 34 |
2019 |
Alternative retinoid X receptor (RXR) ligands. |
NRs, RXR |
| 35 |
2019 |
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening. |
--- |
| 36 |
2019 |
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype. |
--- |
| 37 |
2019 |
Genomic and non-genomic pathways are both crucial for peak induction of neurite outgrowth by retinoids. |
RA, RARs |
| 38 |
2019 |
Ligand Design for Modulation of RXR Functions. |
ant, HTS, NR |
| 39 |
2019 |
Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors. |
--- |
| 40 |
2019 |
Recent insights on the role and regulation of retinoic acid signaling during epicardial development. |
RAR |
| 41 |
2019 |
Regulation of cellular senescence by retinoid X receptors and their partners. |
SASP |
| 42 |
2019 |
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models. |
LG268 |
| 43 |
2019 |
Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice. |
sRXRms |
| 44 |
2019 |
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. |
PPARs |
| 45 |
2018 |
A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics. |
CTCL |
| 46 |
2018 |
Bexarotene cannot reduce amyloid beta plaques through inhibition of production of amyloid beta peptides: in silico and in vitro study. |
APOE4, PPARgamma |
| 47 |
2018 |
Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation. |
--- |
| 48 |
2018 |
DHA upregulates FADS2 expression in primary cortical astrocytes exposed to vitamin A. |
ALA, DHA, PA, PPARs, VA |
| 49 |
2018 |
Effects of thyroid hormone disruption on the ontogenetic expression of thyroid hormone signaling genes in developing zebrafish (Danio rerio). |
DIOs, NCOAs, NCORs, PTU, THs |
| 50 |
2018 |
In silico molecular interaction of bisphenol analogues with human nuclear receptors reveals their stronger affinity vs. classical bisphenol A. |
BPA, PPARs |
| 51 |
2018 |
Modulation of RXR-DNA complex assembly by DNA context. |
DR1, NMR |
| 52 |
2018 |
Prenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARgamma Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain Neurons. |
BP-3, PPARgamma |
| 53 |
2018 |
Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work? |
CR, MF, OR, RARs |
| 54 |
2018 |
RXR Ligands Modulate Thyroid Hormone Signaling Competence in Young Xenopus laevis Tadpoles. |
Bex, TBT, TH, TREs, TRs |
| 55 |
2018 |
Scaffold hopping from synthetic RXR modulators by virtual screening and de novo design. |
--- |
| 56 |
2017 |
A multi-tiered, in vivo, quantitative assay suite for environmental disruptors of thyroid hormone signaling. |
BDE-47, NF, pf, TBBPA, TH, TRs |
| 57 |
2017 |
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). |
HSCs, NAFLD, NASH, PNPLA3I148M, RARs, RBP4 |
| 58 |
2017 |
Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma. |
AHR, BAL, LXRs, NR, OVA, PAS, PPARs, RARs, VDRs |
| 59 |
2017 |
Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization. |
AF-2, NURR1 |
| 60 |
2017 |
Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice. |
ABCA1, APOE, LXRs |
| 61 |
2017 |
Retinoids Regulate Adipogenesis Involving the TGFbeta/SMAD and Wnt/beta-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells. |
hBMSCs, PPARgamma, RARs, shRNA, TGF-beta |
| 62 |
2017 |
RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification. |
LXR, NR, RAR |
| 63 |
2017 |
The multi-faceted role of retinoid X receptor in bone remodeling. |
NR |
| 64 |
2016 |
An Endogenous Mammalian Retinoid X Receptor Ligand, At Last! |
--- |
| 65 |
2016 |
Decreased Expression of Retinoid X Receptors During Human and Azoxymethane-induced Colorectal Carcinogenesis in the Rat. |
AOM |
| 66 |
2016 |
Effect of LXR/RXR agonism on brain and CSF Abeta40 levels in rats. |
AD, APOE, CSF, LXRs |
| 67 |
2016 |
EPA/DHA and Vitamin A Supplementation Improves Spatial Memory and Alleviates the Age-related Decrease in Hippocampal RXRgamma and Kinase Expression in Rats. |
DHA, EPA, RARs |
| 68 |
2016 |
Natural and Structure-based RXR Ligand Scaffolds and Their Functions. |
NR |
| 69 |
2016 |
Preclinical PET Neuroimaging of [11C]Bexarotene. |
PET |
| 70 |
2016 |
Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor. |
--- |
| 71 |
2016 |
Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity. |
PPARgamma |
| 72 |
2016 |
Retinoids and rexinoids in cancer prevention: from laboratory to clinic. |
RARs |
| 73 |
2016 |
Solution Behavior of the Intrinsically Disordered N-Terminal Domain of Retinoid X Receptor alpha in the Context of the Full-Length Protein. |
NTD |
| 74 |
2016 |
The combined effects of all-trans-retinoic acid and docosahexaenoic acid on the induction of apoptosis in human breast cancer MCF-7 cells. |
ATRA, DHA, RARs |
| 75 |
2016 |
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis. |
EAE, iTreg, Th |
| 76 |
2015 |
9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice. |
9CDHRA |
| 77 |
2015 |
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity. |
APOE, ES |
| 78 |
2015 |
Cloning, mRNA expression and transcriptional regulation of five retinoid X receptor subtypes in yellow catfish Pelteobagrus fulvidraco by insulin. |
Pf-rxr |
| 79 |
2015 |
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway. |
apoB, CPT I, DQP, EF, FATP, HMGCR, LDL, MI, PPARalpha, TG |
| 80 |
2015 |
Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors. |
9cRA, ATRA, RARs |
| 81 |
2015 |
Elevated Farnesoid XReceptor (FXR) and Retinoid XReceptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma. |
FXR |
| 82 |
2015 |
Identification of Bexarotene as a PPARgamma Antagonist with HDX. |
CTCL, HDX, NRs, PPARgamma |
| 83 |
2015 |
Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1. |
COX-2, LXRs, mPGES-1 |
| 84 |
2015 |
Involvement of Different networks in mammary gland involution after the pregnancy/lactation cycle: Implications in breast cancer. |
NF-kappaB, RARs, TGF-beta |
| 85 |
2015 |
Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells. |
COS, GCs, PPARs |
| 86 |
2015 |
Molecular cloning and expression analysis of the retinoid X receptor (RXR) gene in golden pompano Trachinotus ovatus fed Artemia nauplii with different enrichments. |
dph, RXR |
| 87 |
2015 |
Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. |
AD, RARs |
| 88 |
2015 |
Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses. |
Luc, TH, TR |
| 89 |
2015 |
Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages. |
9cRA, ABCA1, AP-1, JNK, LXRs, PI3K, PKC |
| 90 |
2015 |
Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages. |
9cRA, ABCA1, AP-1, JNK, LXRs, PI3K, PKC |
| 91 |
2015 |
Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. |
LXR, MAFB, SREBP-1c |
| 92 |
2015 |
Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors. |
BRET, CoA, Luc, NRs, PCA, YFP |
| 93 |
2015 |
Structural basis of natural promoter recognition by the retinoid X nuclear receptor. |
DBD, DR1 |
| 94 |
2015 |
The Continuing Failure of Bexarotene in Alzheimer's Disease Mice. |
AD, APOE, BEXA |
| 95 |
2015 |
Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism. |
RA, RARs, VA |
| 96 |
2015 |
TSLP expression in the skin is mediated via RARgamma-RXR pathways. |
AD, ATRA, RARs, VDR |
| 97 |
2014 |
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. |
EGCG, FOXO3a |
| 98 |
2014 |
Architecture of DNA Bound RAR heterodimers. |
RA, RARs |
| 99 |
2014 |
Development of yeast reporter assay for screening specific ligands of retinoic acid and retinoid X receptor subtypes. |
RARs |
| 100 |
2014 |
Diarylamines incorporating hexahydrophenalene or octahydrobenzoheptalene as retinoid X receptor (RXR)-specific agonists. |
RARs, RXR |
|
A Search Service for Abbreviation / Long Form
